BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27993666)

  • 1. Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors.
    Mouracade P; Kara O; Maurice MJ; Dagenais J; Malkoc E; Nelson RJ; Kaouk JH
    J Urol; 2017 Jun; 197(6):1403-1409. PubMed ID: 27993666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors. Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR. J Urol. 2016 Aug;196(2):327-34.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):449-450. PubMed ID: 28416109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
    Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
    J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between R.E.N.A.L. nephrometry score and survival outcomes in renal tumours.
    Zhang X; Sun Q; Qi Y; Chen Y; Xiong Y; Xi W; Miao Z; Li X; Quan X; Lin J
    Jpn J Clin Oncol; 2024 Mar; 54(3):339-345. PubMed ID: 38117949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates.
    Lane BR; Golan S; Eggener S; Tobert CM; Kahnoski RJ; Kutikov A; Smaldone M; Whelan CM; Shalhav A; Uzzo RG
    J Urol; 2013 Jun; 189(6):2047-53. PubMed ID: 23313207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
    Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
    Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.
    Shah PH; Moreira DM; Okhunov Z; Patel VR; Chopra S; Razmaria AA; Alom M; George AK; Yaskiv O; Schwartz MJ; Desai M; Vira MA; Richstone L; Landman J; Shalhav AL; Gill I; Kavoussi LR
    J Urol; 2016 Aug; 196(2):327-34. PubMed ID: 26907508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.
    Bertolo R; Garisto J; Dagenais J; Sagalovich D; Agudelo J; Stein R; Fareed K; Gao T; Fergany A; Kaouk J
    J Urol; 2019 Jan; 201(1):56-61. PubMed ID: 30100402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy.
    Lane BR; Campbell SC; Gill IS
    J Urol; 2013 Jul; 190(1):44-9. PubMed ID: 23306087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
    Wood EL; Adibi M; Qiao W; Brandt J; Zhang M; Tamboli P; Matin SF; Wood CG; Karam JA
    J Urol; 2018 Feb; 199(2):393-400. PubMed ID: 28941919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging strategy and outcome following partial nephrectomy.
    Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
    Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdisciplinary Comparison of PADUA and R.E.N.A.L. Scoring Systems for Prediction of Conversion to Nephrectomy in Patients with Renal Mass Scheduled for Nephron Sparing Surgery.
    Dahlkamp L; Haeuser L; Winnekendonk G; von Bodman C; Frey UH; Epplen R; Palisaar RJ; Bach P; Noldus J; Brock M; Roghmann F
    J Urol; 2019 Nov; 202(5):890-898. PubMed ID: 31145034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
    Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
    World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database.
    Schiavina R; Novara G; Borghesi M; Ficarra V; Ahlawat R; Moon DA; Porpiglia F; Challacombe BJ; Dasgupta P; Brunocilla E; La Manna G; Volpe A; Verma H; Martorana G; Mottrie A
    BJU Int; 2017 Mar; 119(3):456-463. PubMed ID: 27528265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.